Clinical trial
Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C…
NCT00005896 · University of Minnesota, Other · Unknown status
Key facts
| NCT number | NCT00005896 |
|---|---|
| Title | Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia |
| Lead sponsor | University of Minnesota, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fanconi's Anemia |
| Intervention type | Drug, Genetic, Procedure |
| Interventions | filgrastim, Autologous stem cells transduced with FACC retroviral vector, Autologous Stem Cell Transplantation |
| Enrollment | 6 |
| Start date | Mar 1, 2000 |
| First posted | Jun 5, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: